Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria
The PLOS One Staff
PLoS ONE · 2025-04
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0241065.].
MeSH terms
- Rifampicin
- Tuberculosis
- Multi-drug-resistant tuberculosis
- Extensively drug-resistant tuberculosis
- Medicine
- Tb treatment
- Drug resistance
- Drug
- MEDLINE
- Internal medicine
- Pharmacology